XML 31 R20.htm IDEA: XBRL DOCUMENT
v3.25.3

EARNINGS (LOSS) PER SHARE | 9 Months Ended
--- | ---
Sep. 30, 2025
Earnings Per Share [Abstract] |
EARNINGS (LOSS) PER SHARE | EARNINGS (LOSS) PER SHARE The following table presents earnings (loss) per share for the three and nine months ended September 30, 2025 and 2024:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
(shares presented in the table are in thousands) | 2025 |  | 2024 |  | 2025 |  | 2024
Net income (loss) | $ | 21,865 |  |  | $ | (7,903) |  |  | $ | 59,364 |  |  | $ | 8,366 |
Weighted average shares outstanding - basic | 19,224 |  |  | 19,088 |  |  | 19,185 |  |  | 13,298 |
Dilutive effect of share-based compensation | 140 |  |  | 138 |  |  | 160 |  |  | 143 |
Weighted average shares outstanding - diluted | 19,364 |  |  | 19,226 |  |  | 19,345 |  |  | 13,441 |
Per share information: |  |  |  |  |  |  |
Basic earnings (loss) per share | $ | 1.14 |  |  | $ | (0.41) |  |  | $ | 3.09 |  |  | $ | 0.63 |
Diluted earnings (loss) per share | 1.13 |  |  | (0.41) |  |  | 3.07 |  |  | 0.62 |
For the three and nine months ended September 30, 2025, the total average shares of the outstanding antidilutive restricted stock grants were 1,600 and 73,000 shares, respectively, compared to 268,000 and 131,000 shares for the three and nine months ended September 30, 2024, respectively. For the three and nine months ended September 30, 2025, the total average shares of the exercisable antidilutive stock options outstanding were zero and 1,900 shares, respectively. For the three and nine months ended September 30, 2024, there were no antidilutive exercisable stock options. Antidilutive shares are excluded from the computation of earnings per share as the grant price exceeded the average market price. The dilutive effect of share-based compensation in each period above relates to restricted stock awards and vested stock options.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration